[Content uniformity for digoxin tablet]. 1974

H Tokunaga, and T Kimura, and J Kawamura

UI MeSH Term Description Entries
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

H Tokunaga, and T Kimura, and J Kawamura
February 2018, International journal of pharmaceutics,
H Tokunaga, and T Kimura, and J Kawamura
January 1980, Die Pharmazie,
H Tokunaga, and T Kimura, and J Kawamura
May 2012, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists,
H Tokunaga, and T Kimura, and J Kawamura
November 2023, Journal of pharmaceutical and biomedical analysis,
H Tokunaga, and T Kimura, and J Kawamura
November 2007, Bosnian journal of basic medical sciences,
H Tokunaga, and T Kimura, and J Kawamura
January 1984, Journal of pharmaceutical sciences,
H Tokunaga, and T Kimura, and J Kawamura
January 2013, Pharmaceutical development and technology,
H Tokunaga, and T Kimura, and J Kawamura
January 1969, Dansk tidsskrift for farmaci,
H Tokunaga, and T Kimura, and J Kawamura
November 2020, AAPS PharmSciTech,
Copied contents to your clipboard!